HealthEquity Cash Flow from Financial Activities 2014-2024 | HQY
HealthEquity annual/quarterly cash flow from financial activities history and growth rate from 2014 to 2024. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- HealthEquity cash flow from financial activities for the quarter ending April 30, 2024 was $0.052B, a 201.46% decline year-over-year.
- HealthEquity cash flow from financial activities for the twelve months ending April 30, 2024 was $-0.100B, a 78.97% increase year-over-year.
- HealthEquity annual cash flow from financial activities for 2024 was $-0.047B, a 1661.1% increase from 2023.
- HealthEquity annual cash flow from financial activities for 2023 was $-0.003B, a 100.68% decline from 2022.
- HealthEquity annual cash flow from financial activities for 2022 was $0.395B, a 653.24% increase from 2021.
| HealthEquity Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $-47 |
| 2023 | $-3 |
| 2022 | $395 |
| 2021 | $52 |
| 2020 | $1,466 |
| 2019 | $23 |
| 2018 | $15 |
| 2017 | $24 |
| 2016 | $37 |
| 2015 | $90 |
| 2014 | $-5 |
| 2013 | $-7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.373B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.556B | 15.38 |
| Cencora (COR) | United States | $47.310B | 18.44 |
| ICON (ICLR) | Ireland | $26.285B | 24.82 |
| DiDi Global (DIDIY) | China | $21.823B | 0.00 |
| Avantor (AVTR) | United States | $14.665B | 21.59 |
| CochLear (CHEOY) | Australia | $14.459B | 0.00 |
| Natera (NTRA) | United States | $13.261B | 0.00 |
| Revvity (RVTY) | United States | $13.239B | 23.22 |
| Medpace Holdings (MEDP) | United States | $12.486B | 41.08 |
| Viatris (VTRS) | United States | $11.966B | 3.58 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.394B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.807B | 20.69 |
| Solventum (SOLV) | United States | $9.209B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.426B | 0.00 |
| Organon (OGN) | United States | $5.233B | 4.96 |
| Bausch + Lomb (BLCO) | Canada | $5.186B | 20.76 |
| Doximity (DOCS) | United States | $5.110B | 35.79 |
| PACS (PACS) | United States | $4.461B | 0.00 |
| Life Times (LTH) | United States | $3.655B | 38.29 |
| Sotera Health (SHC) | United States | $3.210B | 15.75 |
| Surgery Partners (SGRY) | United States | $3.184B | 29.13 |
| GoodRx Holdings (GDRX) | United States | $3.062B | 116.57 |
| Agilon Health (AGL) | United States | $2.772B | 0.00 |
| Progyny (PGNY) | United States | $2.450B | 42.18 |
| NovoCure (NVCR) | Jersey | $2.092B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.996B | 7.91 |
| Premier (PINC) | United States | $1.906B | 8.15 |
| BrightSpring Health Services (BTSG) | United States | $1.802B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.711B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.444B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.197B | 0.00 | |
| CareDx (CDNA) | United States | $0.733B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.721B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| Pediatrix Medical (MD) | United States | $0.649B | 6.88 |
| Auna S.A (AUNA) | Luxembourg | $0.592B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| InnovAge Holding (INNV) | United States | $0.575B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.435B | 43.40 |
| ModivCare (MODV) | United States | $0.381B | 7.12 |
| Sonida Senior Living (SNDA) | United States | $0.379B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| DocGo (DCGO) | United States | $0.318B | 17.39 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| MultiPlan (MPLN) | United States | $0.246B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.237B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.107B | 51.51 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| Oncology Institute (TOI) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |